317 related articles for article (PubMed ID: 35247611)
1. Serum amyloid A1 exacerbates hepatic steatosis via TLR4-mediated NF-κB signaling pathway.
Jiang B; Wang D; Hu Y; Li W; Liu F; Zhu X; Li X; Zhang H; Bai H; Yang Q; Yang X; Ben J; Chen Q
Mol Metab; 2022 May; 59():101462. PubMed ID: 35247611
[TBL] [Abstract][Full Text] [Related]
2. Regulation of lipid-induced macrophage polarization through modulating peroxisome proliferator-activated receptor-gamma activity affects hepatic lipid metabolism via a Toll-like receptor 4/NF-κB signaling pathway.
Wu HM; Ni XX; Xu QY; Wang Q; Li XY; Hua J
J Gastroenterol Hepatol; 2020 Nov; 35(11):1998-2008. PubMed ID: 32128893
[TBL] [Abstract][Full Text] [Related]
3. ADAR2 deficiency ameliorates non-alcoholic fatty liver disease and muscle atrophy through modulating serum amyloid A1.
Kung ML; Yang TH; Lin CC; Ho JY; Hung TC; Chang CH; Huang KW; Chen CC; Chen YW
J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):949-962. PubMed ID: 38533529
[TBL] [Abstract][Full Text] [Related]
4. Alternate-day fasting protects the livers of mice against high-fat diet-induced inflammation associated with the suppression of Toll-like receptor 4/nuclear factor κB signaling.
Yang W; Cao M; Mao X; Wei X; Li X; Chen G; Zhang J; Wang Z; Shi J; Huang H; Yao X; Liu C
Nutr Res; 2016 Jun; 36(6):586-93. PubMed ID: 27188904
[TBL] [Abstract][Full Text] [Related]
5. Hepatocytes derived increased SAA1 promotes intrahepatic platelet aggregation and aggravates liver inflammation in NAFLD.
Li D; Xie P; Zhao S; Zhao J; Yao Y; Zhao Y; Ren G; Liu X
Biochem Biophys Res Commun; 2021 May; 555():54-60. PubMed ID: 33813276
[TBL] [Abstract][Full Text] [Related]
6. Loss of RIP3 initiates annihilation of high-fat diet initialized nonalcoholic hepatosteatosis: A mechanism involving Toll-like receptor 4 and oxidative stress.
Chenxu G; Minxuan X; Yuting Q; Tingting G; Jing F; Jinxiao L; Sujun W; Yongjie M; Deshuai L; Qiang L; Linfeng H; Xuyuan N; Mingxing W; Ping H; Jun T
Free Radic Biol Med; 2019 Apr; 134():23-41. PubMed ID: 30599260
[TBL] [Abstract][Full Text] [Related]
7. Huangqin decoction mitigates hepatic inflammation in high-fat diet-challenged rats by inhibiting TLR4/NF-κB/NLRP3 pathway.
Yan BF; Wang Y; Wang WB; Ding XJ; Wei B; Liu SJ; Fu TM; Chen L; Zhang JZ; Liu J; Zheng X
J Ethnopharmacol; 2023 Mar; 303():115999. PubMed ID: 36509260
[TBL] [Abstract][Full Text] [Related]
8. Allyl isothiocyanate ameliorates lipid accumulation and inflammation in nonalcoholic fatty liver disease
Li CX; Gao JG; Wan XY; Chen Y; Xu CF; Feng ZM; Zeng H; Lin YM; Ma H; Xu P; Yu CH; Li YM
World J Gastroenterol; 2019 Sep; 25(34):5120-5133. PubMed ID: 31558861
[TBL] [Abstract][Full Text] [Related]
9. Long-term subcutaneous injection of lipopolysaccharides and high-fat diet induced non-alcoholic fatty liver disease through IKKε/ NF-κB signaling.
He Q; Zeng J; Yao K; Wang W; Wu Q; Tang R; Xia X; Zou X
Biochem Biophys Res Commun; 2020 Nov; 532(3):362-369. PubMed ID: 32883523
[TBL] [Abstract][Full Text] [Related]
10. Targeting DUSP7 signaling alleviates hepatic steatosis, inflammation and oxidative stress in high fat diet (HFD)-fed mice via suppression of TAK1.
Wu L; Liu Y; Zhao Y; Li M; Guo L
Free Radic Biol Med; 2020 Jun; 153():140-158. PubMed ID: 32311490
[TBL] [Abstract][Full Text] [Related]
11. Nuclear factor high-mobility group box1 mediating the activation of Toll-like receptor 4 signaling in hepatocytes in the early stage of nonalcoholic fatty liver disease in mice.
Li L; Chen L; Hu L; Liu Y; Sun HY; Tang J; Hou YJ; Chang YX; Tu QQ; Feng GS; Shen F; Wu MC; Wang HY
Hepatology; 2011 Nov; 54(5):1620-30. PubMed ID: 21809356
[TBL] [Abstract][Full Text] [Related]
12. Fibrinogen-like protein 2 aggravates nonalcoholic steatohepatitis via interaction with TLR4, eliciting inflammation in macrophages and inducing hepatic lipid metabolism disorder.
Hu J; Wang H; Li X; Liu Y; Mi Y; Kong H; Xi D; Yan W; Luo X; Ning Q; Wang X
Theranostics; 2020; 10(21):9702-9720. PubMed ID: 32863955
[No Abstract] [Full Text] [Related]
13. Silencing of SAA1 inhibits palmitate- or high-fat diet induced insulin resistance through suppression of the NF-κB pathway.
Wang Y; Cao F; Wang Y; Yu G; Jia BL
Mol Med; 2019 May; 25(1):17. PubMed ID: 31060494
[TBL] [Abstract][Full Text] [Related]
14. Alleviation of non-alcoholic fatty liver disease by Huazhi Fugan Granules is associated with suppression of TLR4/NF-κB signaling pathway.
Ye M; Tang Y; He J; Yang Y; Cao X; Kou S; Wang L; Sheng L; Xue J
Clin Investig Arterioscler; 2021; 33(5):257-266. PubMed ID: 33810882
[TBL] [Abstract][Full Text] [Related]
15. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
16. WISP1 promotes non-alcoholic fatty liver disease and skeletal muscle insulin resistance via TLR4/JNK signaling.
Jung TW; Kang C; Goh J; Chae SI; Kim HC; Lee TJ; Abd El-Aty AM; Jeong JH
J Cell Physiol; 2018 Aug; 233(8):6077-6087. PubMed ID: 29319180
[TBL] [Abstract][Full Text] [Related]
17. PREX1 depletion ameliorates high-fat diet-induced non-alcoholic fatty liver disease in mice and mitigates palmitic acid-induced hepatocellular injury via suppressing the NF-κB signaling pathway.
Li Z; Wu K; Zou Y; Gong W; Wang P; Wang H
Toxicol Appl Pharmacol; 2022 Aug; 448():116074. PubMed ID: 35605788
[TBL] [Abstract][Full Text] [Related]
18. MFG-E8 Knockout Aggravated Nonalcoholic Steatohepatitis by Promoting the Activation of TLR4/NF-
Hu J; Du H; Yuan Y; Guo P; Yang J; Yin X; Liu J; Wu S; Wan J; Gong X
Mediators Inflamm; 2022; 2022():5791915. PubMed ID: 35769208
[TBL] [Abstract][Full Text] [Related]
19. The capsaicinoid nonivamide suppresses the inflammatory response and attenuates the progression of steatosis in a NAFLD-rat model.
Wikan N; Tocharus J; Oka C; Sivasinprasasn S; Chaichompoo W; Suksamrarn A; Tocharus C
J Biochem Mol Toxicol; 2023 Mar; 37(3):e23279. PubMed ID: 36541345
[TBL] [Abstract][Full Text] [Related]
20. Serum amyloid A1 mediates myotube atrophy via Toll-like receptors.
Hahn A; Kny M; Pablo-Tortola C; Todiras M; Willenbrock M; Schmidt S; Schmoeckel K; Jorde I; Nowak M; Jarosch E; Sommer T; Bröker BM; Felix SB; Scheidereit C; Weber-Carstens S; Butter C; Luft FC; Fielitz J
J Cachexia Sarcopenia Muscle; 2020 Feb; 11(1):103-119. PubMed ID: 31441598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
